STOCK TITAN

Sleep Number Financials

SNBR
Source SEC Filings (10-K/10-Q) Updated Apr 4, 2026 Currency USD FYE January

This page shows Sleep Number (SNBR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SNBR FY2026

A shrinking sales base left stable product margins unable to absorb overhead and a heavy financing burden.

From FY2023 to FY2026, gross margin stayed around 59% even as revenue fell 25.2%; that points to volume deleverage rather than product economics breaking down. At the same time, net loss reached -$132M while operating cash flow was only -$3.3M, showing reported earnings weakened much faster than cash generation.

The balance-sheet cushion is thin: cash was just $1.7M and the current ratio was 0.2x, so day-to-day liquidity depends on turning inventory and receivables into cash quickly. With liabilities of $1.26B against assets of $680.1M, creditors are carrying more of the enterprise than retained capital is.

Even with capital spending down to $14.4M in FY2026, free cash flow was still -$17.7M; the cash strain is coming from weaker operations, not from unusually heavy reinvestment. That matters because FY2024's small positive free cash flow of $3.6M did not mark a durable reset before FY2026 slipped back.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 11 / 100
Financial Profile 11/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Sleep Number's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
20

Sleep Number has an operating margin of -3.3%, meaning the company retains $-3 of operating profit per $100 of revenue. This below-average margin results in a low score of 20/100, suggesting thin profitability after operating expenses. This is down from 1.4% the prior year.

Growth
11

Sleep Number's revenue declined 16.1% year-over-year, from $1.7B to $1.4B. This contraction results in a growth score of 11/100.

Leverage
14

Sleep Number has elevated debt relative to equity (D/E of -2.02), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 14/100, reflecting increased financial risk.

Liquidity
0

Sleep Number's current ratio of 0.15 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
22

While Sleep Number generated -$3.3M in operating cash flow, capex of $14.4M consumed most of it, leaving -$17.7M in free cash flow. This results in a low score of 22/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Weak
2/9

Sleep Number passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality
0.02x

For every $1 of reported earnings, Sleep Number generates $0.02 in operating cash flow (-$3.3M OCF vs -$132.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-0.9x

Sleep Number earns $-0.9 in operating income for every $1 of interest expense (-$46.6M vs $49.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.4B
YoY-16.1%
5Y CAGR-3.6%
10Y CAGR+3.9%

Sleep Number generated $1.4B in revenue in fiscal year 2026. This represents a decrease of 16.1% from the prior year.

EBITDA
$9.0M
YoY-89.9%
5Y CAGR-44.7%
10Y CAGR-22.9%

Sleep Number's EBITDA was $9.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 89.9% from the prior year.

Net Income
-$132.0M
YoY-549.2%

Sleep Number reported -$132.0M in net income in fiscal year 2026. This represents a decrease of 549.2% from the prior year.

EPS (Diluted)
$-5.77
YoY-541.1%

Sleep Number earned $-5.77 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 541.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$17.7M
YoY-586.3%

Sleep Number generated -$17.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 586.3% from the prior year.

Cash & Debt
$1.5M
YoY-23.9%
5Y CAGR-1.4%
10Y CAGR-30.7%

Sleep Number held $1.5M in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
23M
YoY+2.9%
5Y CAGR-3.6%
10Y CAGR-8.3%

Sleep Number had 23M shares outstanding in fiscal year 2026. This represents an increase of 2.9% from the prior year.

Margins & Returns

Gross Margin
59.0%
YoY-0.6pp
5Y CAGR-2.9pp
10Y CAGR-3.7pp

Sleep Number's gross margin was 59.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.6 percentage points from the prior year.

Operating Margin
-3.3%
YoY-4.7pp
5Y CAGR-9.9pp
10Y CAGR-12.7pp

Sleep Number's operating margin was -3.3% in fiscal year 2026, reflecting core business profitability. This is down 4.7 percentage points from the prior year.

Net Margin
-9.3%
YoY-8.1pp
5Y CAGR-14.2pp
10Y CAGR-15.6pp

Sleep Number's net profit margin was -9.3% in fiscal year 2026, showing the share of revenue converted to profit. This is down 8.1 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
$33.9M
YoY-25.0%
5Y CAGR-0.6%
10Y CAGR+13.6%

Sleep Number invested $33.9M in research and development in fiscal year 2026. This represents a decrease of 25.0% from the prior year.

Share Buybacks
$1.2M
YoY+57.9%
5Y CAGR-62.6%
10Y CAGR-29.9%

Sleep Number spent $1.2M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 57.9% from the prior year.

Capital Expenditures
$14.4M
YoY-38.7%
5Y CAGR-24.6%
10Y CAGR-15.4%

Sleep Number invested $14.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 38.7% from the prior year.

SNBR Income Statement

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Revenue $319.0M-8.2% $347.4M+1.3% $342.9M+4.6% $327.9M-16.6% $393.3M+4.4% $376.8M-11.7% $426.6M+4.5% $408.4M
Cost of Revenue $134.4M-12.8% $154.1M+12.1% $137.5M+2.5% $134.2M-12.1% $152.7M+1.0% $151.2M-9.5% $167.1M+0.1% $166.9M
Gross Profit $184.6M-4.5% $193.3M-5.9% $205.4M+6.0% $193.7M-19.5% $240.5M+6.6% $225.6M-13.1% $259.5M+7.5% $241.5M
R&D Expenses $5.3M-15.0% $6.3M-14.2% $7.3M-22.2% $9.4M-13.6% $10.9M+2.3% $10.7M+0.7% $10.6M-8.6% $11.6M
SG&A Expenses $33.6M+9.6% $30.7M-3.6% $31.8M+7.4% $29.6M-23.3% $38.6M+1.0% $38.2M+15.6% $33.1M-16.4% $39.6M
Operating Income -$36.9M-357.7% -$8.1M+80.0% -$40.3M-53653.3% -$75K-104.1% $1.9M-33.4% $2.8M-67.1% $8.4M+37.8% $6.1M
Interest Expense $13.1M-5.6% $13.9M+9.4% $12.7M+8.1% $11.7M+5.9% $11.1M-5.6% $11.7M-2.6% $12.1M-1.7% $12.3M
Income Tax $338K-99.1% $36.6M+376.9% -$13.2M-200.1% $13.2M+2356.9% -$585K+86.4% -$4.3M-779.1% -$489K+55.5% -$1.1M
Net Income -$50.3M+14.1% -$58.6M-47.2% -$39.8M-59.1% -$25.0M-189.3% -$8.6M-85.3% -$4.7M-48.8% -$3.1M+37.9% -$5.1M
EPS (Diluted) $-2.19 N/A $-1.73-58.7% $-1.09-186.8% $-0.38 N/A $-0.14+36.4% $-0.22

SNBR Balance Sheet

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Total Assets $641.0M-5.7% $680.1M-9.3% $749.4M-6.9% $804.5M-3.9% $836.8M-2.8% $860.8M-0.4% $864.7M-2.1% $883.6M
Current Assets $143.5M-4.3% $150.0M-11.7% $169.8M-3.3% $175.5M+0.1% $175.4M-3.3% $181.3M+6.5% $170.3M-4.0% $177.4M
Cash & Equivalents $1.5M-12.3% $1.7M+33.9% $1.3M-6.3% $1.3M-20.2% $1.7M-13.3% $1.9M+22.5% $1.6M-21.2% $2.0M
Inventory $78.2M-4.9% $82.2M-8.5% $89.8M-9.7% $99.5M-4.3% $103.9M+0.7% $103.2M+10.9% $93.0M-2.9% $95.8M
Accounts Receivable $13.4M-13.9% $15.5M+11.5% $13.9M-13.2% $16.0M+12.6% $14.2M-18.8% $17.5M+2.9% $17.0M-16.0% $20.3M
Goodwill $64.0M0.0% $64.0M0.0% $64.0M0.0% $64.0M0.0% $64.0M0.0% $64.0M0.0% $64.0M0.0% $64.0M
Total Liabilities $1.3B+0.7% $1.3B-1.0% $1.3B-1.1% $1.3B-0.7% $1.3B-1.4% $1.3B-0.1% $1.3B-1.3% $1.3B
Current Liabilities $931.7M+2.1% $912.5M+1.5% $898.8M-0.5% $903.2M-0.1% $904.4M-0.4% $908.0M+1.6% $894.0M-0.7% $900.6M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$626.3M-8.3% -$578.5M-11.0% -$521.3M-8.5% -$480.7M-5.2% -$456.8M-1.2% -$451.6M-0.6% -$448.8M-0.4% -$447.0M
Retained Earnings -$661.5M-8.2% -$611.2M-10.6% -$552.6M-7.8% -$512.9M-5.1% -$487.8M-1.8% -$479.2M-1.0% -$474.5M-0.7% -$471.4M

SNBR Cash Flow Statement

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Operating Cash Flow -$7.8M-513.2% $1.9M+129.5% -$6.4M-266.3% $3.8M+245.5% -$2.6M+88.9% -$23.7M-186.7% $27.3M+367.0% -$10.2M
Capital Expenditures $5.4M+116.0% $2.5M-34.3% $3.8M+11.1% $3.5M-24.9% $4.6M-26.8% $6.3M+100.0% $3.1M-34.1% $4.8M
Free Cash Flow -$13.2M-1951.6% -$643K+93.7% -$10.2M-2861.8% $369K+105.1% -$7.2M+75.9% -$30.0M-224.0% $24.2M+261.2% -$15.0M
Investing Cash Flow -$5.4M-116.0% -$2.5M+34.3% -$3.8M+43.0% -$6.7M-46.4% -$4.6M+26.8% -$6.3M-110.5% -$3.0M+37.3% -$4.8M
Financing Cash Flow $13.0M+1111.1% $1.1M-89.4% $10.1M+293.4% $2.6M-63.1% $7.0M-77.0% $30.3M+222.5% -$24.7M-265.6% $14.9M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $373K+92.3% $194K+158.7% $75K-80.3% $381K-32.3% $563K+1307.5% $40K-65.5% $116K+176.2% $42K

SNBR Financial Ratios

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Gross Margin 57.9%+2.2pp 55.6%-4.3pp 59.9%+0.8pp 59.1%-2.1pp 61.2%+1.3pp 59.9%-1.0pp 60.8%+1.7pp 59.1%
Operating Margin -11.6%-9.2pp -2.3%+9.4pp -11.8%-11.7pp -0.0%-0.5pp 0.5%-0.3pp 0.7%-1.2pp 2.0%+0.5pp 1.5%
Net Margin -15.8%+1.1pp -16.9%-5.3pp -11.6%-4.0pp -7.6%-5.4pp -2.2%-1.0pp -1.2%-0.5pp -0.7%+0.5pp -1.2%
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -7.8%+0.8pp -8.6%-3.3pp -5.3%-2.2pp -3.1%-2.1pp -1.0%-0.5pp -0.5%-0.2pp -0.4%+0.2pp -0.6%
Current Ratio 0.15-0.0 0.16-0.0 0.190.0 0.190.0 0.190.0 0.200.0 0.190.0 0.20
Debt-to-Equity -2.02+0.2 -2.18+0.3 -2.44+0.2 -2.67+0.2 -2.83+0.1 -2.91+0.0 -2.93+0.1 -2.98
FCF Margin -4.1%-4.0pp -0.2%+2.8pp -3.0%-3.1pp 0.1%+1.9pp -1.8%+6.1pp -8.0%-13.6pp 5.7%+9.3pp -3.7%

Note: Shareholder equity is negative (-$626.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.15), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Sleep Number (SNBR) reported $1.4B in total revenue for fiscal year 2026. This represents a -16.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Sleep Number (SNBR) revenue declined by 16.1% year-over-year, from $1.7B to $1.4B in fiscal year 2026.

No, Sleep Number (SNBR) reported a net income of -$132.0M in fiscal year 2026, with a net profit margin of -9.3%.

Sleep Number (SNBR) reported diluted earnings per share of $-5.77 for fiscal year 2026. This represents a -541.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sleep Number (SNBR) had EBITDA of $9.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Sleep Number (SNBR) had a gross margin of 59.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Sleep Number (SNBR) had an operating margin of -3.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Sleep Number (SNBR) had a net profit margin of -9.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Sleep Number (SNBR) generated -$17.7M in free cash flow during fiscal year 2026. This represents a -586.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Sleep Number (SNBR) generated -$3.3M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Sleep Number (SNBR) had $641.0M in total assets as of fiscal year 2026, including both current and long-term assets.

Sleep Number (SNBR) invested $14.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Sleep Number (SNBR) invested $33.9M in research and development during fiscal year 2026.

Yes, Sleep Number (SNBR) spent $1.2M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Sleep Number (SNBR) had 23M shares outstanding as of fiscal year 2026.

Sleep Number (SNBR) had a current ratio of 0.15 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

Sleep Number (SNBR) had a debt-to-equity ratio of -2.02 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Sleep Number (SNBR) had a return on assets of -20.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2026 data, Sleep Number (SNBR) had $1.5M in cash against an annual operating cash burn of $3.3M. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Sleep Number (SNBR) has negative shareholder equity of -$626.3M as of fiscal year 2026, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Sleep Number (SNBR) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Sleep Number (SNBR) has an earnings quality ratio of 0.02x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Sleep Number (SNBR) has an interest coverage ratio of -0.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Sleep Number (SNBR) scores 11 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top